#USA #LabConnect #biotechnology #Raleigh-Durham #Raleigh, North Carolina

LabConnect Expands Global Headquarters in Raleigh-Durham

LabConnect, recognized worldwide as a leading partner for central laboratory solutions, recently unveiled its new global headquarters in Raleigh, North Carolina. This strategic move strengthens their footprint in the Research Triangle, an area renowned for its biotechnology and pharmaceutical firms, making it a prime location to enhance LabConnect's operational efficiency and market presence.

The new office is strategically positioned to facilitate collaboration with sponsors and contract research organizations (CROs), ultimately enhancing LabConnect’s ability to support complex clinical trials globally. With an impressive network of renowned research universities and a highly skilled workforce, the Research Triangle is a hotspot for innovation in the life sciences sector. The establishment of LabConnect's headquarters here signifies an important alignment with key stakeholders in drug development, allowing for more effective engagement and partnership.

Wes Wheeler, CEO of LabConnect, emphasized the significance of this new location, stating, "With this new branch in Raleigh, we are right where our customers make some of their most important decisions regarding drug development. RDU has become one of the world’s foremost centers for pharmaceutical innovations. By strengthening our company presence here, we can work even more closely with our clients, attract outstanding talent, and accelerate the development of new therapies for patients in need."

LabConnect's new facility will complement its existing global network, which includes seven other locations across North America, Latin America, Europe, and Asia. This strategic geographic distribution not only assists in meeting the needs of both emerging and large biopharmaceutical customers but also ensures that LabConnect can provide tailored solutions in sample management, data integration, and technology-enabled services right at the doorstep of its clients.

In the coming years, LabConnect plans to expand its Raleigh office team, adding roles in commercial leadership, project management, scientific operations, technology, and data science. This growth reflects LabConnect’s commitment to creating a modern, collaborative workplace that leverages the strengths of the RDU market while maintaining its global, asset-light operating model and flexible partner laboratory network.

About LabConnect

LabConnect redefines central laboratory services as a technology-driven partner for pharmaceutical and biotechnology companies. Their decentralized network model offers sponsors access to the industry's most comprehensive global testing portfolio, supported by advanced sample tracking, data management, and expert consulting services. Their asset-light approach encompasses functional service solutions, specialty testing, and complementary support—providing scalability and efficiency that transcends traditional laboratory ownership.

For more information about LabConnect, follow them on LinkedIn or visit their official website at www.labconnect.com.

This expansion marks a pivotal step for LabConnect as it positions itself at the heart of biotechnology innovation, ensuring a proactive approach to the continuously evolving needs of the pharmaceutical industry. As LabConnect solidifies its presence in Raleigh, it is well-poised to make significant contributions to the future of drug development.